---
schema_version: "secwatch.filing_event.v1"
accession: "0001792044-26-000025"
form_type: "8-K"
ticker: "VTRS"
cik: "0001792044"
company_name: "Viatris Inc"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:57:21.593817+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Viatris Q1 revenues $3.5B (+8% YoY), adj. EBITDA $1.0B, reaffirms FY guidance

## Summary
- Total revenues $3.5B, up 8% reported and 3% operational vs Q1 2025.
- US GAAP net earnings $176M; Adjusted EBITDA $1.0B, +10% operationally.
- Reaffirms 2026 financial guidance; expects >$2.5B cash available for deployment.
- Launched Effexor for generalized anxiety disorder in Japan; pipeline milestones progressing.

## SEC filing metadata
- accession: 0001792044-26-000025
- form_type: 8-K
- ticker: VTRS
- cik: 0001792044
- company_name: Viatris Inc
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792044/000179204426000025/0001792044-26-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792044/000179204426000025/vtrs-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001792044-26-000025
- JSON: https://secwatch.observer/filing/0001792044-26-000025.json
- Plain text: https://secwatch.observer/filing/0001792044-26-000025.txt

## Source-grounded claims
- claim_id: 701a9d850d8e1d42ce5a6d5fe3a7606098514de7
  claim: Viatris Inc updated its first-quarter 2026 guidance (reaffirmed).
  evidence_excerpt: On May 7, 2026 , Viatris Inc. (“Viatris” or the “Company”) issued a press release reporting the Company's financial results for the period ended March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792044/000179204426000025/0001792044-26-000025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.